1. Home
  2. KEP vs ILMN Comparison

KEP vs ILMN Comparison

Compare KEP & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korea Electric Power Corporation

KEP

Korea Electric Power Corporation

HOLD

Current Price

$17.26

Market Cap

17.8B

Sector

Utilities

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$132.07

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEP
ILMN
Founded
1961
1998
Country
South Korea
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical Specialities
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8B
18.9B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
KEP
ILMN
Price
$17.26
$132.07
Analyst Decision
Hold
Analyst Count
0
15
Target Price
N/A
$114.93
AVG Volume (30 Days)
427.1K
1.6M
Earning Date
11-14-2025
10-30-2025
Dividend Yield
0.28%
N/A
EPS Growth
122.08
N/A
EPS
9.13
4.46
Revenue
$69,245,145,923.00
$4,288,000,000.00
Revenue This Year
$5.38
N/A
Revenue Next Year
$2.36
$2.08
P/E Ratio
$3.79
$29.62
Revenue Growth
5.27
N/A
52 Week Low
$6.68
$68.70
52 Week High
$18.29
$153.06

Technical Indicators

Market Signals
Indicator
KEP
ILMN
Relative Strength Index (RSI) 56.49 68.77
Support Level $17.13 $126.44
Resistance Level $17.83 $129.72
Average True Range (ATR) 0.37 4.12
MACD -0.11 -0.41
Stochastic Oscillator 50.83 79.08

Price Performance

Historical Comparison
KEP
ILMN

About KEP Korea Electric Power Corporation

Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: